Tuesday, 12 May 2026

'Magic Mushrooms' Could be New Solution to Quitting Smoking

BT Lifestyle Desk
Disclosure : 02 May 2026, 01:32 PM
Johns Hopkins study, 52% of participants using psilocybin therapy remained abstinent from smoking after six months.
Johns Hopkins study, 52% of participants using psilocybin therapy remained abstinent from smoking after six months.

New research suggests that psychedelic drugs could help smokers overcome nicotine addiction by fundamentally shifting their worldview and life priorities.

Nicotine is notoriously difficult to quit, often compared to the addictive grip of cocaine or heroin. While 70% of smokers express a desire to stop, fewer than 10% succeed annually. However, a groundbreaking study from Johns Hopkins University indicates that psilocybin the active compound in "magic mushrooms" could offer a powerful alternative to traditional methods.

The Power of Perspective

According to Matthew Johnson, a professor at Johns Hopkins, the effectiveness of psychedelics may be philosophical. Participants in a 2026 study reported a sudden shift in values, feeling that smoking no longer served their life goals. "The magnitude of the experience overshadowed the psychological challenge of quitting," Johnson noted.

In a trial involving 82 participants, those who received a high dose of psilocybin combined with talk therapy were significantly more successful than those using nicotine patches. Six months later, 52% of the psilocybin group remained smoke-free, compared to just 25% of the patch group.

How It Works: Reopening the Brain

Scientists believe the drug creates "behavioral plasticity." Neuroscientists at UC Berkeley suggest psychedelics may reopen "critical periods" in the brain windows of heightened learning usually seen in childhood. When combined with cognitive behavioral therapy, this allows the brain to "reprogram" itself and break long-standing habits.

A Cautious Path Forward

Despite the excitement, experts urge caution. Psychedelics remain illegal in most countries, and research is tightly controlled. Critics point out that current studies are small and lacked diversity. To address this, the U.S. National Institutes of Health (NIH) recently awarded a $4 million grant the first in 50 years for psychedelic therapy to conduct a larger, multi-site trial.

While addiction remains a complex issue, researchers believe integrating psychedelics with therapy and healthy habits like mindfulness could provide a creative solution to the world's leading preventable cause of death.

  • Latest

  • Popular

Dial Karim Arrested in Chittagong With Firearm

1

Chittagong Port Holds Firefighting Drill for Port Safety Week

2

Former Agrani Bank Official Sentenced to 8 Years for Embezzlement

3

10 Injured in Clash Between UP Chairman and Traders in Pabna

4

Govt to Prioritize Domestic Coal and Stone Over Imports: Energy Adviser

5

Land Dispute in Muksudpur Dispute Over DCR-Allocated Land

6

9 More Children Die From Measles and Related Symptoms

7

Finance Minister: No Political Interference in Economic Sector

8

Historic Rani Rashmoni Estate’s Kachari House set for preservation in Narail

9

Development planning meeting to make Paikgachha Municipality a model municipality

10

Protest Against Attack During Anti-VC Movement at PSTU

11

Coordinated Measures Strengthen Security at Chittagong Port

12

NCP forms second committee in two weeks in Lakshmipur

13

Measles investigation committee to be formed: Information Advisor

14

3 Natural Herbs to Soothe Sunburn and Skin Damage

15

Mobile Court Seizes Banned Fishing Nets in Mohanganj

16

Body of missing girl recovered from Madhumoti river

17

Bangladesh to Receive 100,000 Tons Crude Oil via Ship

18

Shibsa Literary Center Committee Formed in Paikgachha

19

Central Committee of Rural Doctors Holds Exchange Meeting in Jhalakathi

20